Trinity Biotech Plc
Research Trinity Biotech Plc (TRIB) on Bullrun: market cap USD 8.46M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTRIB
- ExchangeNASDAQ
- CountryIreland
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 8.46M
- Financial periodQ4 2025
- RevenueUSD 43.79M
- Net income-USD 37.38M
- Free cash flow-USD 12.15M
- Gross margin38.6%
Valuation Snapshot
latest market cap is USD 8.46M.
About Trinity Biotech Plc
Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases, such as syphilis and herpes; SARS-CoV-2;
Frequently asked questions
What is Trinity Biotech Plc's market cap?
Trinity Biotech Plc's market capitalization is USD 8.46M.
What does Trinity Biotech Plc do?
Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe.